Neoadjuvant Therapy With Nab-paclitaxel and Cisplatin for Locally Advanced Esophageal Squamous Cell Carcinoma

Clinical trial NCT03964753 · RECRUITING

Trial details

NCT number: NCT03964753
Sponsor: Hebei Medical University Fourth Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Esophageal Squamous Cell Carcinoma

Start date: 2019-04-24
Primary completion: 2026-06-24
Enrollment: 202

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.